SCYX: SCYNEXIS, Inc. Company Profile & Statistics

SCYNEXIS, Inc. Profile

About

SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.

Info & Links

CEO

David Angulo

Headquarters

1 EVERTRUST PLAZA, 13TH FLOOR
JERSEY CITY, NJ 07302, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

SCYNEXIS, Inc. Statistics

Valuation Measures

Market Capitalization²

39.35M

Enterprise Value

18.01M

Enterprise Value/EBITDA(ttm)

-1.14

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.90

Price to Book(mrq)

0.74

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-56.00%

Profit Margin(ttm)

-1277.21%

Return on Equity(ttm)

-25.52%

Return on Invested Capital(ttm)

-24.91%

Return on Assets(ttm)

-19.33%

Income Statement

Revenue(ttm)

20.60M

Revenue Per Share(ttm)

0.46

Gross Profit(ttm)

20.60M

EBITDA(ttm)³

-15.76M

Net Income Available to Common(ttm)

-8.61M

Diluted EPS(ttm)

-0.17

Share Statistics

Beta (5Y Monthly)

1.33

52-Week Change

-15.38%

S&P 500 52-Week Change

15.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

44.66M

Dividend Yield

0.00%

Float⁴

42.49M

% Held by Insiders

4.86%

% Held by Institutions

54.37%

Balance Sheet

Total Cash(mrq)

40.11M

Total Cash Per Share(mrq)

0.90

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.04%

Quick Ratio(mrq)

7.04%

Book Value Per Share(mrq)

1.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.11

Free Cash Flow(ytd)

-5.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SCYX

SCYNEXIS, Inc.